1. Preventing Meningococcal B Disease

3. Meningococcal Disease

4. Incidence of Meningococcal Disease High in Adolescents

5. Epidemiology and Burden of Meningococcal Disease in the United States

6. Highest Incidence of Meningococcal Disease in Infants < 1 Year: Serogroup B Predominates

7. Who’s at Risk?

8. Meningitis Belt in Sub-Saharan Africa Areas With Frequent Epidemics of Meningococcal Meningitis

9. Dr Effiong Shares His Personal Experience

10. Incidence of Meningococcal Disease: All Age Groups

11. The 5 Primary Serogroups of Neisseria meningitidis Bacteria in the United States

12. Incidence of Meningococcal Disease: Adolescents

13. Are Adolescents Entering College at Increased Risk?

14. Recent Meningococcal B Disease Outbreaks on US College Campuses

15. Meningococcal Vaccines Approved for Use in the United States

16. ACIP Recommendations

17. Category A Recommendations for A, C, W, Y (All Adolescents)

18. Meningococcal Vaccines: Category A Recommendations (High-Risk)

19. MenB Vaccines: Safety

20. Meningococcal Vaccine Dosing Schedules

21. Meningococcal Vaccines: Having the Conversation With Parents

22. Establish Consistent Vaccine Messages in Your Practice Setting

23. Important Points About the Second Dose of MenB

24. IAC Resources

25. Concluding Remarks

26. Abbreviations